Akebia Therapeutics, Inc. (AKBA) has 98 open-market insider trades by 19 insiders since 2014. Over the last six months insiders net sold $62K. The most active filer is Michel Dahan, COO & VP.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Muneer A. Satter | Dir | — | 13 | $20.7M | 2017-07-05 |
| Novartis Bioventures Ltd | 10% | — | 1 | $3.1M | 2014-03-25 |
| A/s Novo | 10% | — | 1 | $3.1M | 2014-03-25 |
| John P. Butler | CEOPres | — | 12 | $1.7M | 2026-08-06 |
| Michel Dahan | COOVP | — | 17 | $753K | 2024-05-13 |
| Nicole R. Hadas | CLOVP | — | 17 | $703K | 2024-05-13 |
| Steven Keith Burke | VP | — | 12 | $400K | 2026-02-02 |
| Dell Faulkingham | CCO | — | 4 | $203K | 2022-03-01 |
| Jason Amello | CFOVPTreasurer | — | 3 | $203K | 2020-02-28 |
| Adrian Adams | Dir | — | 1 | $171K | 2026-06-17 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Erik Ostrowski | CFO & VP +1 | Sell | $62K | 2026-06-29 |
| John P. Butler | President | Buy | $87K | 2026-03-04 |
| Erik Ostrowski | CFO & Treasurer +1 | Sell | $49K | 2026-02-02 |
| Nicholas Grund | Chief Commercial Officer | Sell | $118K | 2026-02-02 |
| Steven Keith Burke | SVP & Chief Medical Officer | Sell | $94K | 2026-02-02 |
| John P. Butler | President | Sell | $474K |
Companies that share insiders with AKBA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2026-02-02 |
| Carolyn M. Rucci | CLO & SVP | Sell | $97K | 2026-02-02 |
| Richard C. Malabre | SVP & Chief Accounting Officer | Sell | $69K | 2026-02-02 |
| Erik Ostrowski | CFO & VP +1 | Sell | $303K | 2025-06-30 |
| Richard C. Malabre | CAO & VP | Sell | $60K | 2025-06-09 |
| Richard C. Malabre | SVP & Chief Accounting Officer | Sell | $47K | 2025-06-04 |
| John P. Butler | CEO & President | Sell | $170K | 2025-03-03 |
| Steven Keith Burke | SVP & Chief Medical Officer | Sell | $13K | 2025-03-03 |
| John P. Butler | CEO & President | Sell | $606K | 2025-02-03 |
| Nicholas Grund | CCO | Sell | $234K | 2025-02-03 |